✦ LIBER ✦

Phase II study of gemcitabine in advanced colorectal adenocarcinoma

✍ Scribed by Dennis F. Moore; Richard Pazdur; Karen Daugherty; Peter Tarassoff; James L. Abbruzzese

Publisher: Springer US
Year: 1992
Tongue: English
Weight: 267 KB
Volume: 10
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00944189

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of amonafide in advanced

Phase II study of amonafide in advanced pancreatic adenocarcinoma

✍ Kaye Linke; Richard Pazdur; James L. Abbruzzese; Jaffer A. Ajani; Rodger Winn; J 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 262 KB

To determine the efficacy of amonafide in patients with advanced, measurable pancreatic adenocarcinoma, 15 patients previously untreated with chemotherapy were entered on a phase II trial. The starting dose was 400 mg/m 2 administered daily over 1 hr for 5 consecutive days repeated every 3 weeks. Be

Phase II study of gemcitabine in patient

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Tai-Shen Yang; Yung-Chang Lin; Jen-Shi Chen; Hung-Ming Wang; Chen-Hsu Wang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 3 views

Phase II trial of gemcitabine in advance

Phase II trial of gemcitabine in advanced sarcomas

✍ Scott Okuno; John Edmonson; Michelle Mahoney; Jan C. Buckner; Stephen Frytak; Ev 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

## Abstract ## BACKGROUND Care for patients with advanced sarcomas is mainly palliative. Gemcitabine, a nucleoside antimetabolite, is an analog of deoxycytidine that has shown antitumor activity in several tumors. The aim of the current study was to determine the clinical activity of gemcitabine i

Phase II study of didemnin B in advanced

Phase II study of didemnin B in advanced colorectal cancer

✍ Dennie V. Jones; Jaffer A. Ajani; Roxann Blackburn; Karen Daugherty; Bernard Lev 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 222 KB

A Phase II study of gemcitabine and cisp

A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer

✍ Seung Tai Kim; Joon Oh Park; Jeeyun Lee; Kyu Taek Lee; Jong Kyun Lee; Seong-Ho C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 3 views

Phase II study of spirogermanium in pati

Phase II study of spirogermanium in patients with advanced colorectal carcinoma

✍ Jaffer A. Ajani; Jack S. Faintuch; Roxann K. McClure; Bernard Levin; Bruce M. Bo 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 193 KB

Twenty one evaluable patients with advanced colorectal carcinoma were treated with continuous infusion of spirogermanium at a median daily dose of 150 mg/rn 2 (range 120-210) for five consecutive days every 14 days. Treatments were accomplished by using outpatient infusion devices. Fifteen patients